Serologic versus molecular testing for screening for hepatitis C virus infection in patients with hematologic malignancies

Testing for antibody against hepatitis C virus (anti-HCV) is a low-cost diagnostic method worldwide; however, an optimal screening test for HCV in patients with cancer has not been established. We sought to identify an appropriate screening test for HCV infection in patients with hematologic maligna...

Descripción completa

Detalles Bibliográficos
Autores principales: Torres, Harrys A., Angelidakis, Georgios, Jiang, Ying, Economides, Minas, Mustafayev, Khalis, Yibirin, Marcel, Orlowski, Robert, Champlin, Richard, Verstovsek, Srdan, Raad, Issam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478288/
https://www.ncbi.nlm.nih.gov/pubmed/36123927
http://dx.doi.org/10.1097/MD.0000000000030608

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478288/
https://www.ncbi.nlm.nih.gov/pubmed/36123927
http://dx.doi.org/10.1097/MD.0000000000030608

Ejemplares similares